Alieus Hedge Fund Receives Expression of Interest for Series B Funding

New Delhi [India], March 20: Alieus Hedge Fund is pleased to announce that it has received expressions of interest for Series B funding, following its decision to decline Series A offers from various venture capital financing companies. This move underscores the firm’s strategic approach to securing the right investment partners who align with its long-term vision and growth objectives.

With approximately $30 million in Assets Under Management (AUM) and regulatory approvals under Luxembourg RAIF and the Cayman Islands Monetary Authority (CIMA), Alieus Hedge Fund continues to strengthen its position as a leading player in the alternative investment space. The interest in Series B funding highlights investor confidence in the firm’s business model, performance, and future potential.

Mr. Ashish Jain, Founder & CEO of Alieus Hedge Fund, commented: “We carefully evaluated our Series A funding options and chose to decline offers that did not align with our strategic direction. The strong interest in our Series B round reflects our continued growth and ability to attract investors who share our long-term vision.”

Alieus Hedge Fund has been expanding rapidly, attracting investors from India, the UK, Malaysia, Singapore, Mexico, and other regions. The firm has hosted high-profile investor events in Dubai, Thailand, Singapore, Azerbaijan, Mauritius, Georgia, Vietnam, Indonesia, Malaysia, Sri Lanka, and Hong Kong. Additionally, its recent application for Alternative Investment Fund (AIF) registration in India further solidifies its regulatory standing.

The Series B funding round is expected to support Alieus Hedge Fund’s next phase of expansion, including new investment strategies, technological advancements, and broader market reach. The firm remains committed to delivering strong, risk-adjusted returns while maintaining a focus on transparency and regulatory compliance.

About Alieus Hedge Fund:

Alieus Hedge Fund is a global investment firm specializing in alternative investments and hedge fund strategies. With a growing AUM of $30 million and regulatory oversight in Luxembourg and the Cayman Islands, the firm continues to expand its global presence and offer innovative investment solutions to its investors.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Business

Fischer Medical Subsidiary, Time Medical India, Collaborates with Dr. Cherian to Pioneer Next-Generation AI-Enabled MRI System

Mumbai (Maharashtra) [India], November 4: Fischer Medical Ventures Limited (FISCHER | 524743 | INE771F01041), Time Medical International Ventures (I) P LTD, the wholly owned subsidiary of Fischer Medical Ventures Limited, today announced a strategic collaboration with globally acclaimed neurosurgeon, educator, and innovator Dr Iype Cherian. The collaboration’s sole purpose is the development of DRIS–iMRI Medharanya, a […]

Read More
Agartala Business Dr. Saikat Kar innovation Neurotech Startup Science

From Agartala to Global Innovation: How Tripura’s First Neurotech Startup is Bridging Brain Science with Grassroots Impact

Agartala (Tripura) [India], November 4: In a region celebrated for tea gardens and handicrafts rather than technological ambition, a quiet revolution is unfolding. Codonmind Nexus Private Limited, the Northeast’s pioneering neurotechnology startup, is developing brain-computer interface devices and advanced neurological research tools positioned to compete with national players in a market projected to reach USD […]

Read More
Business Harsheep Hortico Limited

Harshdeep Hortico Reports Strong H1 FY26 with Net Profit of INR 5.7 crore

Mumbai (Maharashtra) [India], November 4: Harsheep Hortico Limited (BSE: HARSHDEEP), specializing in the manufacture and export of pots, planters, garden accessories, and outdoor furniture; announced its Unaudited financials for H1 FY26. Key H1 FY25 Financial Highlights Key Financial Highlights (Consolidated) – H1 FY2025-26 Revenue for H1 FY2025–26 was ₹37.84 crore, compared to ₹24.09 crore in […]

Read More